Boditech Med Inc. (KOSDAQ:206640)
16,270
+180 (1.12%)
May 30, 2025, 3:30 PM KST
Boditech Med Revenue
Boditech Med had revenue of 39.10B KRW in the quarter ending March 31, 2025, with 18.14% growth. This brings the company's revenue in the last twelve months to 144.17B, up 4.59% year-over-year. In the year 2024, Boditech Med had annual revenue of 138.16B with 2.94% growth.
Revenue (ttm)
144.17B
Revenue Growth
+4.59%
P/S Ratio
2.46
Revenue / Employee
279.93M
Employees
515
Market Cap
354.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 138.16B | 3.94B | 2.94% |
Dec 31, 2023 | 134.22B | 16.14B | 13.67% |
Dec 31, 2022 | 118.08B | -39.63B | -25.13% |
Dec 31, 2021 | 157.71B | 13.58B | 9.42% |
Dec 31, 2020 | 144.13B | 71.33B | 97.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 3.15B |
PharmaResearch | 392.31B |